Revance Therapeutics, Crown Labs Again Extend Tender Offer Deadline

WSJOct 18 21:58

Mizuho Securities Maintains Revance Therapeutics(RVNC.US) With Hold Rating

Futu NewsOct 17 23:31 · Ratings

Revance Therapeutics (RVNC) Gets a Hold From Mizuho Securities

TipRanksOct 17 23:16 · Ratings

Analysts Have Conflicting Sentiments on These Healthcare Companies: Trevi Therapeutics (TRVI), Conmed (CNMD) and Revance Therapeutics (RVNC)

TipRanksOct 4 21:20 · Ratings

Express News | Revance Therapeutics: Extends Tender Offer Commencement Date to Oct 18

BreakingsOct 4 19:35

Down -17.96% in 4 Weeks, Here's Why Revance Therapeutics (RVNC) Looks Ripe for a Turnaround

Zacks Sep 27 21:00